Intuitive Surgical

Historical price data

Intuitive Surgical's mission is to make minimally invasive surgery the standard of care worldwide through its advanced robotic systems. The company has achieved unparalleled success, with over 8,800 da Vinci systems installed globally and a market capitalization exceeding $161 billion, built on a powerful recurring revenue model from instruments, accessories, and services. Its strategy focuses on deepening penetration in core procedures, expanding into new anatomical areas like the lung with Ion, and enhancing its digital ecosystem to improve surgical outcomes and hospital efficiency.

Intuitive's core technology is the da Vinci robotic-assisted surgical platform, which integrates 3DHD vision, wristed instruments, and an immersive console to enable minimally invasive complex surgery. This is complemented by the Ion platform for robotic-assisted bronchoscopy and a growing suite of digital tools for surgical analytics and training.

Intuitive faces its most significant competitive threat in years, primarily from Medtronic's Hugo RAS system and Johnson & Johnson's developing Ottava platform. However, Intuitive maintains a formidable moat through its vast installed base, unparalleled clinical evidence, deep surgeon training programs, and fully integrated ecosystem of hardware, instruments, and data.